During the past 35 years, there has been a geometric expansion of the population of patients receiving chronic dialysis therapy in the United States. As the size and associated costs of the dialysis population have grown, there has been a consistent and evolving emphasis on measuring and improving the quality of dialysis care. These efforts, aided by robust data collection vehicles, have translated into defined clinical performance measures; nevertheless, morbidity and mortality rates remain high for the dialysis population. Recently, attention has focused on whether improved outcomes could be obtained by paying physicians and dialysis providers on the basis of quality metrics. The feasibility, value, pitfalls, and appropriate quality metrics in a "payment-for-quality" program for dialysis care are currently under vigorous discussion.

中文翻译：

---

终末期肾脏疾病的质量指标。

在过去的35年中，美国接受慢性透析治疗的患者人数呈几何级数增长。随着透析人群的规模和相关费用的增长，对衡量和改善透析护理质量的关注一直在不断发展。在强大的数据收集工具的帮助下，这些努力已转化为明确的临床表现指标；然而，透析人群的发病率和死亡率仍然很高。最近，注意力集中在付费医生和透析提供者是否可以基于质量指标获得更好的结果上。目前正在积极讨论透析护理“按质量付费”计划中的可行性，价值，陷阱和适当的质量指标。